Dr. Gopeshwar Narayan
Professor
Ph.D. (BHU)
Contact Information:
Office: Department of Molecular & Human Genetics Banaras Hindu University Varanasi 221 005.
Home: T - 32, Thyagraj colony Banaras Hindu University Varanasi -221 005.
Contact: +91-542-670-2497 (O); +91-945-001-3701(R)
Email Id:[email protected] 		Employee No. 17693
 
 
Academic Qualifications:
 
S. No.DegreeInstitutionYear
1.B.Sc.Banaras Hindu University1982
2.M.Sc.Banaras Hindu University1985
3.Ph.D. Banaras Hindu University 1994
 
Area of specialization:

Molecular Genetics and Cytogenetics: My research laboratory is working on the molecular pathology of cervical carcinogenesis, gastric cancer, gallbladder cancer and leukemias. We are particularly interested in the study of molecular mechanisms of genetic and epigenetic regulation of tumorigenesis. We are actively working on functional characterization of deregulated genetic pathways and identification of diagnostic, prognostic genetic markers and therapeutic targets in multiple cancers.

 
 

Additional Information/ Achievements:

  1. Professional experience:1. August 1994 - August 1995: Visiting Scientist, Federal Ministry of Research and Technology of Germany, Humboldt University, Berlin, Germany.
  2. 2. September 1995 - November 2000: Assistant Cytogeneticist cum Lecturer, Guru Nanak Dev University, Amritsar, India.
  3. 3. November 2000 - August 2004: Postdoctoral Research Scientist, Department of Pathology, College of Physicians & Surgeons, Columbia University, New York, USA.
  4. 4. September 2004 - March 2006: Associate Research Scientist, Department of Pathology, College of Physicians & Surgeons, Columbia University, New York, USA.
  5. 5. March 2006 - March 2009: Reader, Department of Molecular & Human Genetics, Banaras Hindu University, Varanasi, India.
  6. 6. March 2009 -March 2012: Associate Professor, Department of Molecular & Human Genetics, Banaras Hindu University, Varanasi, India.
  7. 7. March 2012 - Present: Professor, Department of Molecular & Human Genetics, Banaras Hindu University, Varanasi, India.

List of 10 best publications: (in order of importance)

  1. 1. Narayan G, Pulido HA, Koul S, Vargas H, Zhang FF, Villella J, Schneider A, Terry MB, Mansukhani M, Murty VV (2003): Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: Relationship to clinical outcome. Molecular Cancer, 2: 24.
  2. 2. Narayan G, Pulido HA, Koul S, Lu X-Y, Harris CP, Yeh YA, Vargas H, Posso H, Terry MB, Gissmann L, Schneider A, Mansukhani M, Rao PH, Murty VVVS (2003): Genetic analysis identifies putative tumor suppressor sites at 2q34-q35 and 2q36.3-q37.1 involved in cervical cancer progression. Oncogene, 22: 3489-3499.
  3. 3. Narayan G, Pulido HA, Nandula SV, Basso K, Sugirtharaj DD, Vargas H, Villella J, Meyer L, Schneider A, Gissmann L, D�rst M, Pothuri B, Murty VVVS (2004): Promoter hypermethylation of FANCF: Disruption of fanconi anemia-BRCA pathway in cervical cancer. Cancer Research, 64: 2994-2997.
  4. 4. Das M, Prasad SB, Yadav SS, Modi A, Singh S, Pradhan S, Narayan G (2015): HPV type specific response of cervical cancer cells to cisplatin after silencing replication licensing factor MCM4. Tumor Biology, 36: 9987-9994.
  5. 5. Yadav SS, Prasad SB, Prasad CB, Pandey LK, Pradhan S, Singh S, Narayan G (2016): CXCL12 is a key regulator in tumor microenvironment of cervical cancer: an in vitro study. Clinical and Experimental Metastasis. 33:431-439.
  6. 6. Prasad CB, Prasad SB, Yadav SS, Pandey LK, Singh S, Pradhan S, Narayan G (2017): Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property. Scientific Reports, 7: 12876.
  7. 7. Prasad SB, Yadav SS, Das M, Govardhan HB, Pandey LK, Singh S, Pradhan S, Narayan G (2014): Down regulation of FOXO1 promotes cell proliferation in cervical cancer. Journal of Cancer,
  8. 5: 655-662.
  9. 8. Prasad SB, Yadav SS, Das M, Modi A, Kumari S, Pandey LK, Singh S, Pradhan S, Narayan G (2015): PI3K/AKT pathway-mediated regulation of p27Kip1 is associated with cell cycle arrest and apoptosis in cervical cancer. Cellular Oncology, 38: 215-225.
  10. 9. Das M, Prasad SB, Yadav SS, Govardhan HB, Pandey LK, Singh S, Pradhan S, Narayan G (2013): Over expression of minichromosome maintenance genes is clinically correlated to cervical carcinogenesis. PLoS One, 8: e69607.
  11. 10. Mishra D, Singh S, Narayan G (2016): Curcumin induces apoptosis in pre-B acute lymphoblastic leukemia cell lines via PARP-1 cleavage. Asian Pacific Journal of Cancer Prevention, 17: 3865-3869.

A. Full List of publications:

  1. 1. Narayan G, Raman R (1995): Cytological Evaluation of Global DNA Methylation in Mouse Genome. Hereditas, 123: 275-283.
  2. Raman R, Narayan G (1995): 5-Azadeoxycytidine-induced Inhibition of Differentiation of Spermatogonials into Spermatocytes in the Mouse. Molecular Reproduction and Development, 42: 284-290.
  3. 2. Su Z-Z, Gopalkrishnan RV, Narayan G, Dent P, Fisher PB (2002): Progression Elevated Gene-3, PEG-3, Induces Genomic Instability in Rodent and Human Tumor Cells. Journal of Cellular Physiology, 192: 34-44.
  4. 3. Pulido HA, Narayan G, Vargas H, Wheeler CM, Mansukhani M, Murty VVVS (2002): Mapping Common Deleted Regions on 5p15 in Cervical Carcinoma and Their Occurrence in Precancerous Lesions. Molecular Cancer, 1:3.
  5. 4. Harris CP, Lu XY, Narayan G, Singh B, Murty VVVS, Rao PH (2003): Comprehensive Molecular Cytogenetic Characterization of Cervical Carcinoma Cell Lines. Genes Chromosomes & Cancer, 36: 233-241.
  6. 5. Narayan G, Pulido HA, Koul S, Vargas H, Zhang FF, Villella J, Schneider A, Terry MB, Mansukhani M, Murty VV (2003): Frequent Promoter Methylation of CDH1, DAPK, RARB, and HIC1 Genes in Carcinoma of Cervix Uteri: Relationship to Clinical Outcome. Molecular Cancer, 2: 24.
  7. 6. Narayan G, Pulido HA, Koul S, Lu X-Y, Harris CP, Yeh YA, Vargas H, Posso H, Terry MB, Gissmann L, Schneider A, Mansukhani M, Rao PH, Murty VVVS (2003): Genetic Analysis Identifies Putative Tumor Suppressor Sites at 2q34-q35 and 2q36.3-q37.1 Involved in Cervical Cancer Progression. Oncogene, 22: 3489-3499.
  8. 7. Rao PH, Pulido HA, Lu X-Y, Harris CP, Vargas H, Zhang FF, Narayan G, Schneider A, Terry MB, Murty VVVS (2004): Chromosomal Amplifications, 3q Gain and Deletions of 2q33-q37 are Frequent Genetic Changes in Cervical Carcinoma. BMC Cancer, 4:5.
  9. 8. Jhang JS, Narayan G, Murty VVVS, Mansukhani MM (2004): Renal Oncocytomas with 11q13 Rearrangements: Cytogenetic, Molecular and Immunohistochemical analysis of Cyclin D. Cancer Genetics and Cytogenetics, 149: 114-119.
  10. 9. Michel L, Rodrigues ED, Narayan G, Hernando E, Murty VVVS, Benezra R (2004): Complete Loss of the Tumor Suppressor MAD2 Causes Premature Cyclin B Degradation and Mitotic Failure in Human Somatic Cells. Proceedings of the National Academy of Sciences, USA, 101: 4459-4464.
  11. 10. Narayan G, Raman R (2004): Analysis of Topological Organization of Chromatin During Spermatogenesis in Mouse Testis. Genetics and Molecular Biology, 27: 33-38.
  12. 11. Narayan G, Pulido HA, Nandula SV, Basso K, Sugirtharaj DD, Vargas H, Villella J, Meyer L, Schneider A, Gissmann L, D�rst M, Pothuri B, Murty VVVS (2004): Promoter Hypermethylation of FANCF: Disruption of Fanconi Anemia-BRCA Pathway in Cervical Cancer. Cancer Research, 64: 2994-2997.
  13. 12. Koul S, McKiernan JM, Narayan G, Houldsworth J, Bacik J, Dobrzynski DL, Assaad AM, Mansukhani M, Reuter VE, Bosl GJ, Chaganti RSK, Murty VVVS (2004): Role of Promoter Hypermethylation in Cisplatin Treatment Response in Male Germ Cell Tumors. Molecular Cancer, 3:16.
  14. 13. Murty VV, Narayan G (2005): Detection of hypermethylated genes in women with and without cervical neoplasia. Correspondence. Journal of the National Cancer Institute, 97: 1548.
  15. 14. Narayan G, Goparaju C, Pulido HA, Kaufmann AM, Schneider A, Durst M, Mansukhani M, Pothuri B, Murty VV (2006): Promoter hypermethylation-mediated inactivation of multiple Slit-Robo genes in cervical cancer progression. Molecular Cancer, 5:16.
  16. 15. Narayan G, Bourdon V, Chaganti S, Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, D�rst M,Schneider A, Pothuri B, Mansukhani M, Basso K, Chaganti RSK, Murty VV (2007): Gene Dosage Alterations Revealed by cDNA Microarray Analysis in Cervical Cancer: Identification of Candidate Amplified and Overexpressed Genes. Genes Chromosomes & Cancer, 46: 373-384.
  17. 16. Zudaire E, Cuesta N, Murty V, Woodson K, Adams L, Gonzalez N, Mart�nez A, Narayan G, Kirsch I, Franklin W, Hirsch F, Birrer M, Cuttitta F (2008): The Aryl Hydrocarbon Receptor Repressor is a Putative Tumor Suppressor Gene in Multiple Human Cancers. The Journal of Clinical Investigation, 118: 640-650.
  18. 17. Scotto L, Narayan G, Nandula SV, Subramaniyam S, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, Schneider A, Arias-Pulido H, Murty VV (2008): Integrative Genomics Analysis of Chromosome 5p Gain in Cervical Cancer Reveals Target Over-expressed Genes, including Drosha. Molecular Cancer, 7:58.
  19. 18. Meador JA, Zhao M, Su Y, Narayan G, Geard CR, Balajee AS (2008): Histone H2AX is a critical factor for cellular protection against DNA alkylating agents. Oncogene, 27: 5662�5671.
  20. 19. Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, Murty VV (2008): Identification of Copy Number Gain and Overexpressed Genes on Chromosome Arm 20q by an Integrative Genomic Approach in Cervical Cancer: Potential Role in Progression. Genes Chromosomes & Cancer, 47: 755-765.
  21. 20. Vakiani E, Basso K, Klein U, Mansukhani MM, Narayan G, Smith PM, Murty VV, Dalla-Favera R, Pasqualucci L, Bhagat G (2008): Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. Hematological Oncology, 26:199-211.
  22. 21. Singh S, Cheong N, Narayan G, Sharma T (2009): Burrow characteristics of the co-existing sibling species Mus booduga and Mus terricolor and the genetic basis of adaptation to hypoxic/hypercapnic stress. BMC Ecology, 9:6.
  23. 22. Narayan G, Scotto L, Neelakantan V, Kottoor SH, Wong AHY, Loke S-L, Mansukhani M, Pothuri B, Wright JD, Kaufmann AM, Schneider A, Arias-Pulido H, Tao Q, Murty VV (2009): Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer. Genes Chromosomes & Cancer, 48: 983-992.
  24. 23. Narayan G, Murty VV (2010): Interactive genomic approaches in cervical cancer: implications for molecular pathogenesis. Future Oncology, 10: 1643-1652.
  25. 24. Puneet, Narayan G, Khanna AK (2010): Epigenetics and Cancer. In: Gupta RL (ed) Recent Advances in Surgery�12, Jaypee Brothers Medical Publishers Pvt. Ltd., New Delhi, pp206-213.
  26. 25. Narayan G, Freddy AJ, Xie D, Liyanage H, Clark L, Kisselev S, Kang JU, Nandula S, McGuinn C, Subramaniyam S, Sevilla DW, Alobeid B, Satwani P, Savage D, Bhagat G, Murty VV (2011): Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance. Genes Chromosomes & Cancer, 50: 1043-1053.
  27. 26. Prasad SB, Narayan G (2012): A new insight of GSK3B regulation: implications in cancer therapy. Journal of Scientific Research, Banaras Hindu University, 56: 25-34.
  28. 27. Singh S, Ansari MA, Narayan G (2012). Pathobiology of gallbladder cancer. Journal of Scientific Research, Banaras Hindu University, 56: 35-45.
  29. 28. Singh S, Prasad SB, Yadav SS, Agrawal NK, Narayan G (2012): Association of common variants of CDKN2A/2B rs10811661 (C/T) and WFS1 rs6446482 (C/G) with type 2 diabetes mellitus in Indian population of eastern Uttar Pradesh. Journal of Diabetes & Metabolism, 3: 9.
  30. 29. Pandey A, Chandra S, Chauhan LKS, Narayan G, Chowdhuri DK (2013): Cellular internalization and stress response of ingested amorphous silica nanoparticles in the midgut of Drosophila melanogaster. Biochimica et Biophysica Acta, 1830: 2256-2266.
  31. 30. Singh M, Sharma NK, Prasad SB, Yadav SS, Narayan G, Rai AK (2013): Freshwater cyanobacterium Anabaena doliolum transformed with ApGSMT-DMT exhibited enhanced salt tolerance and protection to nitrogenase activity, but changed its behavior to halophily. Microbiology, 159: 641-648.
  32. 31. Calaf GM, Roy D, Narayan G, Balajee AS (2013): Differential expression of cell adhesion molecules in ionizing radiation induced breast cancer model system. Oncology Reports, 30: 285-291.
  33. 32. Das M, Prasad SB, Yadav SS, Govardhan HB, Pandey LK, Singh S, Pradhan S, Narayan G (2013): Over expression of minichromosome maintenance genes is clinically correlated to cervical carcinogenesis. PLoS One, 8: e69607.
  34. 33. Narayan G, Xie D, Freddy AJ, Ishdorj G, Do C, Satwani P, Liyanage H, Clark L, Kisselev S, Nandula S, Scotto L, Alobeid B, Savage D, Tycko B, O�Connor OA, Bhagat G, Murty VV (2013): PCDH10 promoter is frequently methylated in most histologic subtypes of mature lymphoid malignancies and its occurrence is an early event in lymphomagenesis. Genes Chromosomes & Cancer, 52: 1030�1041.
  35. 34. Mishra OP, Singh AK, Kumar B, Batra VV, Narayan G, Prasad R, Pohl M. (2013): Efficacy of oral galactose in children with steroid resistant idiopathic nephrotic syndrome. Pediatric Nephrology, 28: 1594.
  36. 35. Mishra OP, Singh AK, Pohl M, Kumar B, Batra VV, Narayan G (2014): Oral galactose in children with focal and segmental glomerulosclerosis: a novel adjunct therapy. Clinical Kidney Journal, 7: 83�85.
  37. 36. Calaf GM, Balajee AS, Montalvo-Villagra MT, Leon M, Navarrete DM, Alvarez RG, Roy D, Narayan G, Abarca-Quinones J (2014): Vimentin and Notch as biomarkers for breast cancer progression. Oncology Letters, 7: 721-727.
  38. 37. Yadav SS, Narayan G (2014): Role of ROBO4 Signalling in developmental and pathological angiogenesis. BioMed Research International, 2014: 683025.
  39. 38. Prasad SB, Yadav SS, Das M, Govardhan HB, Pandey LK, Singh S, Pradhan S, Narayan G (2014): Down regulation of FOXO1 promotes cell proliferation in cervical cancer. Journal of Cancer, 5: 655-662.
  40. 39. Kumari S, Mishra SP, Rahul, Prasad SB, Yadav SS, Das M, Kumar M, Nath G, Khanna A, Dixit VK, Puneet, Singh S, Narayan G (2014): Differential expression of COX-2: a potential marker for clinical phenotypes of gastric cancer. International Journal of Advanced Research, 2: 278-288.
  41. 40. Mishra OP, Kakani N, Singh AK, Narayan G, Abhinay A, Prasad R, Batra VV (2014): NPHS2 R229Q polymorphism in steroid resistant nephrotic syndrome: Is it responsive to immunosuppressive therapy? Journal of Tropical Pediatrics, 60: 231-237.
  42. 41. Pandey A, Vimal D, Chandra S, Saini S, Narayan G, Chowdhuri DK (2014): Long term dietary exposure to low concentration of dichloroacetic acid promoted longevity and attenuated cellular and functional declines in aged Drosophila melanogaster. AGE (Dordr), 36: 9628.
  43. 42. Yadav SS, Prasad SB, Das M, Kumari S, Swain PK, Pandey LK, Singh S, Pradhan S, Narayan G (2014): Epigenetic silencing of CXCR4 promotes loss of cell adhesion in cervical cancer. BioMed Research International, 2014: 581403.
  44. 43. Srivastava P, Razi SS, Ali R, Gupta RC, Yadav SS, Narayan G, Misra A (2014): Selective naked-eye detection of Hg2+ through an efficient turn-on PET fluorescent probe and its real applications. Analytical Chemistry, 86: 8693-8699.
  45. 44. Das M, Singh S, Pradhan S, Narayan G (2014): MCM paradox: Abundance of eukaryotic replicative helicases and genomic integrity. Molecular Biology International, 2014:574850.
  46. 45. Madeshwaran M, Gupta V, Chakrabarty J, Narayan G, Kumar A (2014): Toll like receptors (TLRs) expression in HIV children. BMC Infectious Diseases, 14: 1-1.
  47. 46. Singh A, Singh AK, Narayan G, Singh TB, Shukla VK (2014): Effect of neem oil and haridra on non-healing wounds. AYU, 35: 398-403.
  48. 47. Chaturmohta A, Dixit R, Narayan G, Gupta P, Prasad SB, Yadav SS, Shukla VK (2015): Do expression profiles of cytokines VEGF, TNF- a, IL-1�, IL-6 and IL-8 correlate with gallbladder cancer? Journal of Cancer Science and Clinical Oncology, 2: 202. ISSN 0171-5216
  49. 48. Pandey A, Khatoon R, Saini S, Vimal D, Kumar Patel D, Narayan G, Kar Chowdhuri D (2015): Efficacy of methuselah gene mutation towards tolerance against dichlorvos exposure to Drosophila melanogaster. Free Radical Biology and Medicine, 83: 54-65.
  50. 49. Prasad SB, Yadav SS, Das M, Modi A, Kumari S, Pandey LK, Singh S, Pradhan S, Narayan G (2015): PI3K/AKT pathway-mediated regulation of p27Kip1 is associated with cell cycle arrest and apoptosis in cervical cancer. Cellular Oncology, 38: 215-225.
  51. 50. Singh SK, Chouhan HS, Sahu AN, Narayan G (2015): Assessment of in vitro antipsoriatic activity of selected Indian medicinal plants. Pharmaceutical Biology, 2015: 1-7.
  52. 51. Sharma V, Jha AK, Kumari A, Bhatnagar A, Narayan G, Kaur J (2015): Curcumin-mediated reversal of p15 gene promoter methylation: Implication in anti-neoplastic action against acute lymphoid leukaemia cell line (curcumin/apoptosis/DNA methyltransferase 1/cell cycle). Folia Biologica (Praha), 61: 81-89.
  53. 52. Yadav SS, Prasad CB, Prasad SB, Pandey LK, Singh S, Pradhan S, Narayan G (2015): Anti-tumor activity of staurosporine in tumor microenvironment of cervical cancer: an in vitro study. Life Sciences, 133: 21-28.
  54. 53. Das M, Prasad SB, Yadav SS, Modi A, Singh S, Pradhan S, Narayan G (2015): HPV type specific response of cervical cancer cells to cisplatin after silencing replication licensing factor MCM4. Tumor Biology, 36: 9987-9994.
  55. 54. Mishra D, Singh VK, Singh S, Narayan G (2015): Molecular modelling-docking cell surface receptor CD10 for doxorubicin. Online Journal of Bioinformatics, 16: 286-292.
  56. 55. Pandey A, Saini S, Khatoon R, Sharma D, Narayan G, Kar Chowdhuri D (2016): Overexpression of hsp27 rescued neuronal cell death and reduction in life- and health-span in Drosophila melanogaster against prolonged exposure to dichlorvos. Molecular Neurobiology. 53: 3179-3193.
  57. 56. Narayan G, Xie D, Ishdorj G, Scotto L, Mansukhani M, Pothuri B, Wright JD, Kaufmann AM, Schneider A, Arias-Pulido H, Murty VV (2016): Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/TRAIL-Cisplatin combination therapy in cervical cancer. Genes Chromosomes & Cancer, 55: 177-189.
  58. 57. Singh S, Agrawal NK, Narayan G (2016): Association of KCNJ11 E23K (rs5219) polymorphism to Type 2 diabetes mellitus: a case-control study in Indian population of Eastern Uttar Pradesh. Diabetes Research and Treatment Open Access, 3: 130.
  59. 58. Yadav SS, Prasad SB, Prasad CB, Pandey LK, Pradhan S, Singh S, Narayan G (2016): CXCL12 is a key regulator in tumor microenvironment of cervical cancer: an in vitro study. Clinical and Experimental Metastasis. 33:431-439.
  60. 59. Mishra OP, Singh AK, Abhinay A, Narayan G, Prasad R, Batra VV (2016): WT1 mutations in steroid-resistant idiopathic nephrotic syndrome. Saudi Journal of Kidney Diseases and Transplantation, 27: 417-418.
  61. 60. Singh M, Modi A, Narayan G, Singh SK (2016): Benzothiazole derivatives bearing amide moiety: potential cytotoxic and apoptosis-inducing agents against cervical cancer. Anticancer Drugs, 27: 519-532.
  62. 61. Kumari S, Puneet, Prasad SB, Yadav SS, Kumar M, Khanna A, Dixit VK, Nath G, Singh S, Narayan G (2016): Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer. Medical Oncology, 33: 40.
  63. 62. Vijayakumar MR, Kosuru R, Singh SK, Prasad CB, Narayan G, Muthu MS, Singh S (2016): Resveratrol loaded PLGA:D-a-tocopheryl polyethylene glycol 1000 succinate blend nanoparticles for brain cancer therapy. RSC Advances, 6: 74254-74268.
  64. 63. Mishra D, Singh S, Narayan G (2016): Curcumin induces apoptosis in pre-B acute lymphoblastic leukemia cell lines via PARP-1 cleavage. Asian Pacific Journal of Cancer Prevention, 17: 3865-3869.
  65. 64. Samaiya PK, Narayan G, Kumar A, Krishnamurthy S (2016): Neonatal anoxia leads to time dependent progression of mitochondrial linked apoptosis in rat cortex and associated long term sensorimotor deficits. International Journal of Developmental Neuroscience, 52: 55-65.
  66. 65. Kazmi HR, Narayan G, Singh S (2016): Retinoblastoma: A review. International Journal of Ocular Oncology and Oculoplasty, 2: 75-79.
  67. 66. Mishra D, Singh S, Narayan G (2016): Role of B Cell Development Marker CD10 in Cancer Progression and Prognosis. Molecular Biology International, 2016:4328697.
  68. 67. Samaiya PK, Narayan G, Kumar A, Krishnamurthy S (2017): Tempol (4 hydroxy-tempo) inhibits anoxia-induced progression of mitochondrial dysfunction and associated neurobehavioral impairment in neonatal rats. Journal of the Neurological Sciences, 375: 58-67.
  69. 68. Mishra OP, Kumar R, Narayan G, Srivastava P, Abhinay A, Prasad R, Singh A, Batra VV (2017): Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome. Pediatric Nephrology, 32: 1355-1361.
  70. 69. Anand V, Basu S, Yadav SS, Narayan G, Bhatia BD, Kumar A (2017): Activation of Toll-like Receptors in Meconium Aspiration Syndrome. Journal of Perinatology, 2017: 1-5.
  71. 70. Prasad CB, Prasad SB, Yadav SS, Pandey LK, Singh S, Pradhan S, Narayan G (2017): Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property. Scientific Reports, 7: 12876.
  72. 71. Puneet, Kazmi HR, Kumari S, Tiwari S, Khanna A, Narayan G (2018): Epigenetic mechanisms and events in gastric cancer-emerging new biomarkers. Pathology & Oncology Research, 24: 757-770.
  73. 72. Samaiya PK, Narayan G, Kumar A, Krishnamurthy S (2018): 2,4 Dinitrophenol attenuates mitochondrial dysfunction and improves neurobehavioral outcomes postanoxia in neonatal rats. Neurotoxicity Research, 34: 121-136.
  74. 73. Maurya L, Rajamanickam VM, Narayan G, Singh S (2018): Vitamin E TPGS emulsified vinorelbine bitartrate loaded solid lipid nanoparticles (SLN): Formulation development, optimization and in vitro characterization. Current Drug Delivery, 15: 1135-1145.
  75. 74. Sharma S, Modi A, Narayan G, Hemalatha S (2018): Protective Effect of Exacum lawii on Cisplatin-induced Oxidative Renal Damage in Rats. Pharmacognosy Magazine, 13: S807-S816.
  76. 75. Mishra OP, Chhabra P, Narayan G, Srivastava P, Prasad R, Singh A, Abhinay A, Batra VV (2019): Cytotoxic T- Lymphocyte Antigen-4 (CTLA4) Gene Expression and Urinary CTLA4 Levels in Idiopathic Nephrotic Syndrome. Indian Journal of Pediatrics, 86: 26-31.
  77. 76. Tripathi D, Modi A, Narayan G, Rai SP (2019): Green and cost effective synthesis of silver nanoparticles from endangered medicinal plant Withania coagulans and their potential biomedical properties. Materials Science & Engineering C, 100: 152-164.
  78. 77. Sharma K, Singh U, Rai M, Shukla J, Gupta V, Narayan G, Kumar S (In Press): Interleukin 6 and disease transformation in chronic myeloid leukemia: A Northeast Indian population study. Journal of Cancer Research and Therapeutics, DOI: 10.4103/jcrt.JCRT_137_17.

B. Chapters contributed to books:
  1. Puneet, Narayan G, Khanna AK (2010): Epigenetics and Cancer. In: Gupta RL (ed) Recent Advances in Surgery�12, Jaypee Brothers Medical Publishers Pvt. Ltd., New Delhi, pp206-213.
  2. Narayan G, Singh S (2016): Molecular Genetics of Cervical Precancerous Lesions: Implications to Prognostic Model Development. In: Cervical Cancer: Recent Research and Review Studies. SM eBooks, pp1-14. ISBN: 978-1-944685-91-1. Narayan G, Singh S (2016): Molecular Genetics of Cervical Precancerous Lesions: Implications to Prognostic Model Development. In: Cervical Cancer: Recent Research and Review Studies. SM eBooks, pp1-14. ISBN: 978-1-944685-91-1.
  3. Narayan G, Singh S (2017): Genetic and epigenetic mechanisms of cervical cancer progression: Integrative genomic approach. In: Human Genomics and Applications, Ed. RC Sobti, Sanjiv Puri, VL Sharma, AJS Bhanwer. Narendra Publishing House, New Delhi, pp1-14. ISBN: 978-93-86110-55-8.
Designed and Developed by: Dr. R.S.Yadava, Computer Centre, BHU     |    Redesigned by: Haribansh Mishra ICT Sector, BHU
© 2018 - , Banaras Hindu University, [BHU], Varanasi-221005, U.P., India.    |    Maintained by : Computer Centre, BHU     |    Use a latest browser for best visibility